A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons

NCT01853085 · clinicaltrials.gov ↗

COMPLETED

Status

1830

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Primary Open Angle
Ocular Hypertension

Interventions

DRUG: Bimatoprost Ophthalmic Solution

Sponsor

Allergan